To examine the role of natural products (NPs) as anticancer agents, with a focus on bioactive compounds derived from the MENA region.
Approach:
Review of Natural Products: The review summarizes MENA-derived NPs that exhibit cytotoxic, antiproliferative, pro-apoptotic, anti-angiogenic, anti-metastatic, and immunomodulatory activities across various preclinical cancer models.
Mechanistic Insights: It discusses the mechanisms of action of these compounds, including their effects on oncogenic signaling networks and cellular processes.
Technological Innovations: Highlights advancements in NP discovery, including high-throughput screening, metagenomics, and synthetic biology techniques.
Key Findings:
The MENA region is a promising source of diverse natural anticancer compounds with various activities.
Natural products demonstrate multiple anticancer activities through distinct mechanisms.
Technological innovations are enhancing the discovery and characterization of novel anticancer agents.
Interpretation:
The MENA region's biodiversity offers significant potential for discovering new anticancer therapies, which could complement existing treatments.
Limitations:
The review does not address specific clinical trials or outcomes related to the discussed compounds.
Challenges in translating findings from preclinical models to clinical applications are not fully explored.
Conclusion:
Harnessing the biodiversity of the MENA region through collaborative research and ethical bioprospecting may lead to innovative cancer therapies.
